Skip to main content
. 2014 Apr 3;94(4):511–521. doi: 10.1016/j.ajhg.2014.02.012

Table 1.

Descriptive Characteristics of Participating Studies

Covariate Discovery
Replication
Multicenter, US
European Studies
Cincinnati, US
Cincinnati, US
GOCHA
HM-ICH + VVH-ICH
JUHSS
LSR
GERFHS I & II
ERICH/GERFHS III/CCC-GCC
Case Cohort Control Cohort Case Cohort Control Cohort Case Cohort Control Cohort Case Cohort Control Cohort Case Cohort Control Cohort Case Cohort Control Cohort
Subjects, n 298 457 212 169 122 163 116 153 797 539 1,681 2,261
Age, mean (SD) 74 (10) 72 (8) 74 (11) 71 (9) 67 (12) 65 (13) 75 (10) 75 (10) 67 (15) 66 (15) 62 (15) 43a (26)
Female, n (%) 134 (45) 231 (51) 103 (49) 77 (46) 69 (57) 93 (57) 49 (42) 69 (45) 383 (48) 243 (45) 701 (42) 1,113 (49)
Hypertension, n (%) 217 (73) 280 (61) 126 (60) 99 (64) 96 (81) 74 (45) 76 (67) 65 (43) 494 (62) 280 (52) 1,009 (60) 738b (51)
Lobar ICH, n (%) 184 (58) 88 (40) 51 (39) 36 (28) 327 (41) 484 (29)
Nonlobar ICH, n (%) 132 (42) 133 (60) 80 (61) 94 (72) 470 (59) 1,197 (71)

Abbreviations are as follows: ICH, intracerebral hemorrhage; GOCHA, Genetics of Cerebral Hemorrhage on Anticoagulation Study; HM-ICH, Hospital del Mar Intracerebral Hemorrhage Study; VVH-ICH, Vall d’Hebron Hospital ICH Study; JUHSS, Jagiellonian University Hemorrhagic Stroke Study; LSR, Lund Stroke Register; GERFHS, Genetic and Environmental Risk Factors for Hemorrhagic Stroke Study; ERICH, Ethnic/Racial Variations of Intracerebral Hemorrhage Study; CCC-GCC, Cincinnati Control Cohort - Genomic Control Cohort.

a

Includes the 819 GCC pediatric control subjects with ages ≤18.

b

Excludes the 819 GCC pediatric control subjects with no hypertension history.